- New and Generic Drug Approvals
- ARESTIN (minocycline hydrochloride) Microspheres, OraPharma Inc., Labeling Revision
- Avelox (moxifloxacin hydrochloride) Tablets, Bayer Pharma, Labeling Revision
- Avelox (moxifloxacin hydrochloride in NaCl) I.V., Bayer Pharma, Labeling Revision
- Irinotecan Hydrochloride Injection, Watson Labs, Approval
- Lexiva (fosamprenavir calcium) Tablets, GlaxoSmithKline, Labeling Revision
- Pramipexole Dihydrochloride Tablets, Barr Labs, Approval
- Reyataz (atazanavir sulfate) Capsules, Bristol-Myers Squibb, Labeling Revision
- Ultram ER Extended-Release Tablets, Biovail Labs, Labeling Revision
tag: FDA Approval, Drug Approval, Ultram, Reyataz, Pramipexole, Lexiva, Irinotecan, Avelox, Avelox, ARESTIN
No comments:
Post a Comment